Analyzes the international drug control regime, examining its legal foundations, emerging tensions, and the existing calls for reform in response to evolving challenges like synthetic drugs, cannabis legalization, and new trafficking methods
The international drug control regime, anchored in three international conventions (1961, 1971, and 1988), bans non-medical drug production and use while ensuring access for medical purposes. Despite near-universal ratification and political commitments focusing on demand and supply reduction as well as judicial cooperation, the illegal drug market has expanded significantly. Over the past decade, drug use rose by 20%, problematic use by 45%, and seizures of drugs like cocaine and amphetamines by more than 40%. These trends expose the regime’s inability to fulfil its objectives, alongside escalating challenges like drug-related violence, overdose crises, and human rights abuses.
This book critically examines the international drug control framework, analyzing its legal instruments, historical context, and implementation mechanisms. It explores emerging tensions, such as the limited access to pain medicines, the legalization of non-medical cannabis in some regions, and synthetic drug crises affecting public health and law enforcement. By addressing these issues, the book sheds light on how countries navigate the conflicts between their international obligations and pressing domestic challenges, particularly in adapting to new trafficking modes.
Building on these analyses, the book discusses whether the current regime is fit for purpose or requires reform. It explores potential pathways for change and evaluates the risks and benefits of maintaining the status quo and of reforming. Ultimately, the work aims to inform policymakers, students, and communities about the complexities of drug control laws and the existing paths to modernization to address contemporary challenges effectively.
The international drug control regime, built on three conventions (1961, 1971, and 1988), prohibits non-medical drug production and use while ensuring access for medical purposes. Despite nearly universal ratification and efforts focused on demand and supply reduction, the illegal drug market has expanded, with drug use increasing by 20% and problematic use by 45% in just a decade. Challenges such as synthetic drug crises, the legalization of non-medical cannabis in some regions, and new trafficking methods like cryptomarkets have highlighted tensions within the regime and its limits in meeting key objectives. This book examines the framework’s legal foundations, implementation, and historical context, alongside emerging tensions and their impact on global norms related to health, development, and human rights. It explores whether the regime remains fit for purpose or requires reform, assessing existing pathways for change and the implications of maintaining the status quo or of reforming. The book provides valuable insights for policymakers, academics, and communities grappling with the modernization of drug control laws in the face of evolving challenges.
This book critically examines the international drug control regime’s legal framework, implementation challenges, and emerging tensions, exploring its failures, the debates on its modernization, and potential reform pathways to address expanding drug markets, public health crises, and human rights concerns in a rapidly evolving global landscape.
Lisainfo e-raamatute kohta